Great West Life Assurance Co. Can lifted its stake in Ingevity Corp (NYSE:NGVT) by 2.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 55,319 shares of the company’s stock after buying an additional 1,298 shares during the period. Great West Life Assurance Co. Can’s holdings in Ingevity were worth $4,273,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in NGVT. U S Global Investors Inc. bought a new position in Ingevity in the fourth quarter valued at approximately $1,077,000. CIBC Asset Management Inc boosted its stake in Ingevity by 47.2% in the fourth quarter. CIBC Asset Management Inc now owns 5,305 shares of the company’s stock valued at $444,000 after acquiring an additional 1,702 shares during the last quarter. Employees Retirement System of Texas boosted its stake in Ingevity by 5.0% in the fourth quarter. Employees Retirement System of Texas now owns 63,000 shares of the company’s stock valued at $5,272,000 after acquiring an additional 3,000 shares during the last quarter. Channing Capital Management LLC boosted its stake in Ingevity by 8.3% in the fourth quarter. Channing Capital Management LLC now owns 724,842 shares of the company’s stock valued at $60,662,000 after acquiring an additional 55,363 shares during the last quarter. Finally, Citigroup Inc. boosted its stake in Ingevity by 56.5% in the fourth quarter. Citigroup Inc. now owns 19,233 shares of the company’s stock valued at $1,610,000 after acquiring an additional 6,940 shares during the last quarter. Institutional investors and hedge funds own 92.81% of the company’s stock.

A number of equities analysts have issued reports on the stock. Zacks Investment Research raised shares of Ingevity from a “hold” rating to a “buy” rating and set a $89.00 price objective on the stock in a research note on Monday, December 31st. ValuEngine raised shares of Ingevity from a “hold” rating to a “buy” rating in a research report on Thursday, February 14th. Loop Capital set a $95.00 price target on shares of Ingevity and gave the stock a “hold” rating in a research report on Thursday, December 13th. Oppenheimer set a $110.00 price target on shares of Ingevity and gave the stock a “buy” rating in a research report on Monday, December 10th. Finally, Jefferies Financial Group set a $68.00 price target on shares of Ingevity and gave the stock a “buy” rating in a research report on Thursday, December 20th. Four equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. Ingevity currently has a consensus rating of “Buy” and an average price target of $100.22.

In related news, EVP Katherine Pryor Burgeson sold 4,400 shares of the business’s stock in a transaction on Monday, February 25th. The shares were sold at an average price of $114.76, for a total value of $504,944.00. Following the sale, the executive vice president now directly owns 8,801 shares of the company’s stock, valued at approximately $1,010,002.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CFO John C. Fortson sold 18,000 shares of the business’s stock in a transaction on Wednesday, February 27th. The shares were sold at an average price of $114.46, for a total transaction of $2,060,280.00. The disclosure for this sale can be found here. Over the last three months, insiders have sold 25,125 shares of company stock worth $2,876,065. Insiders own 0.18% of the company’s stock.

Shares of NYSE NGVT opened at $101.18 on Monday. The firm has a market cap of $4.22 billion, a PE ratio of 24.50, a PEG ratio of 1.91 and a beta of 1.65. Ingevity Corp has a twelve month low of $70.71 and a twelve month high of $120.41. The company has a current ratio of 2.31, a quick ratio of 1.26 and a debt-to-equity ratio of 2.19.

Ingevity (NYSE:NGVT) last announced its quarterly earnings results on Wednesday, February 13th. The company reported $1.07 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.29. The company had revenue of $278.60 million for the quarter, compared to analysts’ expectations of $265.60 million. Ingevity had a net margin of 14.92% and a return on equity of 53.18%. The business’s quarterly revenue was up 21.4% compared to the same quarter last year. During the same period last year, the firm posted $0.45 earnings per share. As a group, equities analysts anticipate that Ingevity Corp will post 4.87 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Great West Life Assurance Co. Can Grows Position in Ingevity Corp (NGVT)” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another site, it was stolen and reposted in violation of U.S. & international copyright and trademark law. The legal version of this story can be viewed at https://www.thecerbatgem.com/2019/03/18/great-west-life-assurance-co-can-grows-position-in-ingevity-corp-ngvt.html.

Ingevity Profile

Ingevity Corporation manufactures and sells specialty chemicals and carbon materials in the United States and internationally. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats.

See Also: Strike Price

Want to see what other hedge funds are holding NGVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ingevity Corp (NYSE:NGVT).

Institutional Ownership by Quarter for Ingevity (NYSE:NGVT)

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.